Search Results - "Mileyko, V."

NGS cfDNA data as a basis for the development of qPCR diagnostic systems by Mileyko, V., Moiseenko, D., Grinchenko, A., Rozhavskaya, E., Kasianov, A.

Get full text

Lessons from the routine tumor molecular profiling in Russia by Mileyko, V., Rozhavskaya, E., Veselovsky, E., Kovtun, A., Ivanov, M., Ignatova, E.O.

Get full text

Design of targeted next-generation sequencing (NGS) of circulating tumour DNA (ctDNA): towards overcoming DNA by Mileyko, V., Ivanov, M., Ignatova, E., Reznik, A., Laktionov, K., Brede, V., Baranova, A.

Get full text

CRAC (Clinical Relevance of Alterations in Cancer): a Knowledge Base for the Selection of Molecularly Matched Therapy for Solid Tumors by Lebedeva, A A, Kavun, A I, Veselovsky, E M, Mileyko, V A, Ivanov, M V

“…Multigene testing using NGS (next-generation sequencing) provides a large amount of information and can detect multiple molecular alterations. Subsequent…”
Get full text

Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment by Guens, G. P., Sanikovich, V. D., Mileyko, V. A., Lebedeva, A. A.

“…Glioblastoma multiforme is the most common and malignant primary tumor of the central nervous system. Despite the existing modern complex therapy and advances…”
Get full text

35P Copy number variation detection from targeted amplicon-based high-throughput sequencing in clinical settings by Yakushina, V., Mileyko, V., Ivanov, M.

Get full text

39P Clinical relevance of alterations in cancer (CRAC): A DB for selecting biomarkers for molecularly matched therapy in cancer patients by Lebedeva, A., Kuznetsova, O.A., Shilo, P., Mileyko, V., Ivanov, M.

Get full text

109P Improved accuracy of somatic variant detection from high throughput sequencing (HTS) data via site-specific noise estimation by Ignatova, E., Ivanov, M., Yakushina, V., Mileyko, V.

Get full text

Human cultured cells are capable to incorporate isolated plant mitochondria loaded with exogenous DNA by Klimenko, E. S., Zaporozhchenko, I. A., Mileyko, V. A., Morozkin, E. S., Koulintchenko, M. V., Laktionov, P. P., Konstantinov, Yu. M .

Get full text

111P Leveraging in silico signatures to predict clinically actionable variants in oncogenes by Veselovsky, E., Yakushina, V., Lebedeva, A., Timokhin, G., Ivanov, M., Mileyko, V.

Get full text

73P Comparison of FDA-approved and laboratory developed next generation sequencing panels in patients with advanced cancers by Kuznetsova, O., Mileyko, V., Fedyanin, M., Ivanov, M., Lebedeva, A., Tryakin, A., Shilo, P.

Get full text

96P Use of computational algorithms to predict mutation effect in clinical setting by Ignatova, E., Yakushina, V., Lebedeva, A., Timokhin, G., Veselovsky, E., Mileyko, V., Ivanov, M.

Get full text

6PNGS cfDNA data as a basis for the development of qPCR diagnostic systems by Mileyko, V, Moiseenko, D, Grinchenko, A, Rozhavskaya, E, Kasianov, A

Get full text

13P Incidental germline findings from tumor molecular profiling for precision oncology: Is it common and how to manage? by Ivanov, M., Lebedeva, A., Seriak, D., Rozhavskaya, E., Sharova, M., Vardhan, D., Baranova, A., Shaykhutdinova, J., Mileyko, V.

Get full text

101PClinical application of routine comprehensive tumour molecular profiling in the management of cancer patients by Mileyko, V, Veselovsky, E, Rozhavskaya, E, Ignatova, E, Kovtun, A, Sharova, M, Ivanov, M

“…Abstract Background Along with the extension of the FDA approved molecular matched therapies, the evidence is building to support molecular profile-based…”
Get full text

Clinical application of routine comprehensive tumour molecular profiling in the management of cancer patients by Mileyko, V., Veselovsky, E., Rozhavskaya, E., Ignatova, E., Kovtun, A., Sharova, M., Ivanov, M.

Get full text

45PLessons from the routine tumor molecular profiling in Russia by Mileyko, V, Rozhavskaya, E, Veselovsky, E, Kovtun, A, Ivanov, M, Ignatova, E O

Get full text

NGS for precision medicine in non-small cell lung cancer: Challenges and opportunities by Mileyko, V., Ivanov, M., Novikova, E., Telysheva, E., Chernenko, P., Breder, V., Laktionov, K., Baranova, A.

Get full text

103P MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience by Lebedeva, A., Belova, E., Grigoreva, T., Kuznetsova, O.A., Kavun, A., Aliyarova, S., Veselovsky, E., Iudina, V., Nikulin, V., Kravchuk, D.A., Fedyanin, M., Mileyko, V., Ivanov, M.V.

Get full text

55P Impact of IHC/PCR discordance on immunotherapy (ICI) response in colorectal cancer (CRC) patients and prospects of liquid biopsy (LB) to replace conventional methods: Survival analysis of BLOOMSI trial by Lebedeva, A., Kuznetsova, O.A., Grigoreva, T., Taraskina, A., Kravchuk, D.A., Belova, E., Kavun, A., Ignatova, E., Veselovsky, E., Belyaeva, L., Nikulin, V., Sergeeva, A., Aliyarova, S., Mileyko, V., Tryakin, A., Fedyanin, M., Ivanov, M.

Get full text